Summary:
Medicare Prescription Drug Abuse Prevention Act of 2016

This bill amends title XVIII (Medicare) of the Social Security Act to: (1) authorize a Medicare prescription drug plan (PDP) sponsor to establish a drug management program under which the PDP sponsor may limit an at-risk beneficiary's access to coverage for frequently abused drugs to include only those drugs that are prescribed by selected prescribers and dispensed by selected pharmacies; and (2) require a PDP sponsor to have in place a utilization management tool to prevent drug abuse.

With respect to a drug management program, a PDP sponsor must: (1) provide specified notice to a beneficiary who has been identified by the Centers for Medicare & Medicaid (CMS) as "at-risk" and consequently enrolled in the program; and (2) in selecting prescribers and dispensers, ensure that the beneficiary continues to have reasonable access to drugs. These determinations shall be subject to expedited reconsideration and appeal. A PDP sponsor must review and consider an at-risk beneficiary's preferences regarding prescriber and pharmacy selection.

Certain individuals, including those receiving hospice care or residing in a long-term care facility, are exempted from enrollment in a drug management program.

CMS must, for purposes of quality or performance assessments, review and consider complaints received from at-risk beneficiaries regarding lack of access due to their enrollment in a drug management program. In addition, CMS must establish rules and procedures requiring a PDP sponsor to provide specified program data.

medicare_prescription_drug abuse prevention act bill amends title xviii medicare social_security_act authorize medicare_prescription_drug plan pdp sponsor establish drug management program pdp sponsor limit risk beneficiary access coverage frequently abused drugs include drugs prescribed selected prescribers dispensed selected pharmacies require pdp sponsor place utilization management tool prevent drug abuse respect drug management program pdp sponsor provide specified notice beneficiary identified centers medicare medicaid cms risk enrolled program selecting prescribers dispensers ensure beneficiary continues reasonable access drugs determinations shall subject expedited reconsideration appeal pdp sponsor review consider risk beneficiary preferences prescriber pharmacy selection certain individuals including receiving hospice care residing long-term_care facility exempted enrollment drug management program cms purposes quality performance assessments review consider complaints received risk beneficiaries lack access enrollment drug management program addition cms establish rules procedures requiring pdp sponsor provide specified program data


Summary:
(This measure has not been amended since it was reported to the House on May 10, 2016. The summary of that version is repeated here.)

John Thomas Decker Act of 2016

(Sec. 2) This bill amends the Public Health Service Act to require the Department of Health and Human Services (HHS) to report on the availability of information regarding prescription of opioids after youth sports injury, including information on opioid use and misuse, injury treatments that do not involve opioids, and treatment for opioid addiction. (Opioids are drugs with effects similar to opium, such as heroin and certain pain medications.) The report must determine the extent this information is available to teenagers and adolescents who play youth sports, their families, youth sports groups, and health care providers.

Taking into consideration the findings of the report, HHS must develop and disseminate such information.

measure amended reported house summary version repeated john thomas act sec bill amends public_health_service_act require department_of_health_and_human_services hhs report availability information prescription opioids youth sports injury including information opioid use misuse injury treatments involve opioids treatment opioid addiction opioids drugs effects similar opium heroin certain pain medications report determine extent information available adolescents play youth sports families youth sports groups health_care providers taking consideration findings report hhs develop disseminate information


Summary:
Synthetic Drug Awareness Act of 2016

This bill requires the Surgeon General to report to Congress on the public health effects of the increased use since January 2010 by individuals who are 12 to 18 years old of drugs developed and manufactured to avoid control under the Controlled Substances Act (e.g., synthetic marijuana, also known as "spice," and synthetic amphetamines, also known as "bath salts").

synthetic drug awareness act bill requires surgeon general report congress public health effects increased use january individuals years old drugs developed manufactured avoid control controlled substances act synthetic marijuana known synthetic known salts


Summary:
Opioid Program Evaluation Act or the OPEN Act

(Sec. 2) This bill directs the Department of Justice (DOJ) to enter into an arrangement with the National Academy of Sciences (NAS) to identify outcomes and develop metrics to evaluate: (1) the incidence of opioid abuse and illegal opioid distribution, and (2) the effectiveness of a DOJ grant program to provide opioid abuse services.

DOJ must publish outcomes and metrics and require grant recipients to collect and report data. The NAS must publish the evaluations.

(Sec. 3) Additionally, the bill directs the Department of Health and Human Services (HHS) to enter into an arrangement with the NAS to identify outcomes and develop metrics to evaluate: (1) the incidence of opioid abuse and illegal opioid distribution, and (2) the effectiveness of HHS grant programs to address opioid abuse.

HHS must publish outcomes and metrics and require grant recipients to collect and report data. The NAS must publish the evaluations.

(Sec. 6) It amends the Justice Assistance Act of 1984 to reduce for FY2022 the authorization of appropriation for financial assistance under the Emergency Federal Law Enforcement Assistance program.

opioid program evaluation act open act sec bill directs department_of_justice doj enter arrangement national_academy_of_sciences nas identify outcomes develop metrics evaluate incidence opioid abuse illegal opioid distribution effectiveness doj grant program provide opioid abuse services doj publish outcomes metrics require grant recipients collect report data nas publish evaluations sec additionally bill directs_the_department_of_health_and_human_services hhs enter arrangement nas identify outcomes develop metrics evaluate incidence opioid abuse illegal opioid distribution effectiveness hhs grant programs address opioid abuse hhs publish outcomes metrics require grant recipients collect report data nas publish evaluations sec amends justice assistance_act reduce fy2022 authorization appropriation financial assistance emergency federal law enforcement assistance program


Summary:
Prescriber Support Act of 2016

This bill amends the Public Health Service Act to authorize the Department of Health and Human Services (HHS) to award grants to states for systems that help prescribers: (1) treat and manage patient pain; and (2) prevent, identify, and respond to patient substance misuse and substance abuse disorders. In awarding grants, HHS must give priority to states with the greatest need.

prescriber support act bill amends public_health_service_act authorize department_of_health_and_human_services hhs award grants states systems help prescribers treat manage patient pain prevent identify respond patient substance misuse substance abuse disorders awarding grants hhs priority states greatest need


Summary:
Opioid and Heroin Abuse Crisis Investment Act of 2016

This bill appropriates funding for the activities in the bill.

This bill amends the Public Health Service Act to require the Department of Health and Human Services to enter into cooperative agreements with states to expand opioid treatment capacity, make services more affordable to those who cannot afford them, and help individuals seek treatment, successfully complete treatment, and sustain recovery. (Opioids are drugs with effects similar to opium, such as heroin and certain pain medications.) Funding must be allocated to states based on the severity of the opioid epidemic in the state and the strength of the state's strategy to respond.

The Office of the National Coordinator for Health Information Technology must expand efforts to support prescription drug monitoring programs and health information technology interoperability.

The Bureau of Prisons must support drug treatment programs.

The bill amends the Second Chance Act to require the Department of Justice (DOJ) to help justice-involved individuals successfully reintegrate into the community.

The bill amends the Controlled Substances Act to permit DOJ to support the development of residential and aftercare services for substance-involved inmates.

DOJ must establish new heroin enforcement groups within the Drug Enforcement Administration to target, disrupt, and dismantle heroin trafficking organizations.

opioid heroin abuse crisis investment act bill appropriates funding activities bill bill amends public_health_service_act require department_of_health_and_human_services enter cooperative agreements states expand opioid treatment capacity services affordable afford help individuals seek treatment successfully complete treatment sustain recovery opioids drugs effects similar opium heroin certain pain medications funding allocated states based severity opioid epidemic state strength state strategy respond office national coordinator health information technology expand efforts support prescription drug monitoring programs health information technology interoperability bureau_of_prisons support drug treatment programs bill amends second chance act require department_of_justice doj help justice involved individuals successfully community bill amends controlled substances act permit doj support development residential aftercare services substance involved inmates doj establish new heroin enforcement groups drug_enforcement_administration target disrupt dismantle heroin trafficking organizations


Summary:
Medicaid Coverage for Addiction Recovery Expansion Act

This bill amends title XIX (Medicaid) of the Social Security Act to allow states to provide medical assistance to adults for residential addiction treatment facility services under the Medicaid program. "Residential addiction treatment facility services" are medically necessary inpatient services provided in an accredited, size-limited facility for the purpose of treating a substance use disorder within a specified time period.

The provision of medical assistance for such services to an individual shall not prohibit federal financial participation for medical assistance with respect to other services provided to the individual within the same time period.

Subject to specified conditions, a woman who is eligible for medical assistance on the basis of being pregnant may remain eligible for residential addiction treatment facility services for specified time periods without regard to eligibility limits that would otherwise apply as a result of her pregnancy ending.

In addition, the bill establishes a grant program for states to expand infrastructure and treatment capabilities of existing youth addiction treatment facilities that: (1) provide addiction treatment services to youths under Medicaid or the Children's Health Insurance Program (CHIP), and (2) are located in communities with high numbers of medically underserved populations of at-risk youths. At least 15% of grant funds awarded to a state must be used for making payments to rural facilities.

medicaid coverage addiction recovery expansion act bill amends title xix medicaid social_security_act allow states provide medical assistance adults residential addiction treatment facility services medicaid program residential addiction treatment facility services medically necessary inpatient services provided accredited size limited facility purpose treating substance use disorder specified time period provision medical assistance services individual shall prohibit federal financial participation medical assistance respect services provided individual time period subject specified conditions woman eligible medical assistance basis pregnant remain eligible residential addiction treatment facility services specified time periods regard eligibility limits apply result pregnancy ending addition bill establishes grant program states expand infrastructure treatment capabilities existing youth addiction treatment facilities provide addiction treatment services youths medicaid children health insurance program chip located communities high numbers medically underserved populations risk youths grant funds awarded state making payments rural facilities


Summary:
Stem the Tide of Overdose Prevalence from Opiate Drugs Act of 2016 or as the STOP OD Act of 2016

This bill permits the Centers for Disease Control and Prevention (CDC) to award grants: (1) to expand educational efforts to prevent abuse of opioids, which are drugs with effects similar to opium, such as heroin; (2) to promote treatment of persons who abuse opioids; and (3) to promote understanding of addiction.

The Department of Health and Human Services (HHS) may award grants to: (1) support first responders carrying and administering naloxone, which is a prescription drug used to rapidly reverse an opioid overdose; (2) establish processes for referral to treatment for opioid abuse; and (3) reimburse for testing for fentanyl in opioid overdoses and reporting the results to the CDC.

This bill amends the Controlled Substances Act to impose a fee on persons convicted of drug offenses. Collected amounts are made available for the HHS grants in this bill.

Specified agencies must submit to the Office of E-Government and Information Technology of the Office of Management and Budget an inventory of agency data centers and a strategy to consolidate and optimize the data centers.

The bill revises reporting requirements for the Department of Defense (DOD) regarding data centers. DOD and the Director of National Intelligence may waive this bill's data center requirements for any national security system.

The bill sets forth requirements for the Office of E-Government and Information Technology, including that the office must publish a goal for cost savings and optimization.

The bill's provisions regarding data centers are repealed at the start of FY2021.

stem tide overdose prevalence opiate drugs act stop act bill permits centers_for_disease_control_and_prevention cdc award grants expand educational efforts prevent abuse opioids drugs effects similar opium heroin promote treatment persons abuse opioids promote understanding addiction department_of_health_and_human_services hhs award grants support responders carrying administering naloxone prescription drug rapidly reverse opioid overdose establish processes referral treatment opioid abuse reimburse testing fentanyl opioid reporting results cdc bill amends controlled substances act impose fee persons convicted drug offenses collected amounts available hhs grants bill specified agencies submit office government information technology office_of_management_and_budget inventory agency data centers strategy consolidate optimize data centers bill revises reporting requirements department_of_defense dod data centers dod director national_intelligence waive bill data center requirements national security system bill sets forth requirements office government information technology including office publish goal cost savings optimization bill provisions data centers repealed start fy2021


Summary:
Addiction Prevention and Responsible Opioid Practices Act

This bill addresses prescription opioid misuse.

 The Food and Drug Administration (FDA) must: (1) seek recommendations concerning opioid drugs from an FDA advisory committee relating to the approval of a new drug that is an opioid, and the labeling of opioid drugs for pediatric prescriptions; (2) develop recommendations for education programs for prescribers of opioids; and (3) issue guidance for labeling that deters opioid abuse.

The bill amends the Federal Food, Drug, and Cosmetic Act by requiring manufacturers of opioid drugs to ensure that certain information about the risk factors associated with opioid drugs are included on the drug labels.

The bill amends the Controlled Substances Act by: (1) addressing annual narcotic manufacturing quotas with respect to fentanyl, oxycodone, hydrocodone, oxymorphone, and hydromorphone; and (2) directing the Department of Justice (DOJ) to require medical practitioners to complete a training program on prescribing opioids for chronic pain before they are certified to prescribe controlled substances in schedule II, III, or IV.

The bill establishes requirements for prescription drug monitoring systems to prevent over-prescribing controlled substances.

The Department of Health and Human Services must: (1) submit a plan of action for addressing outliers in opioid prescribing practices and ensuring an adequate response to protect the public health, and (2) study the expansion of Medicare coverage for alternatives to opioid treatments.

The bill amends the Internal Revenue Code to impose an excise tax on manufacturers or producers of opioid pain relievers. A portion of the amount generated from the tax must be used for substance abuse treatment programs.

DOJ must establish a take-back program for the safe and environmentally responsible disposal of controlled substances.

addiction prevention responsible opioid practices act bill addresses prescription opioid misuse food_and_drug_administration fda seek recommendations concerning opioid drugs fda advisory_committee relating approval new drug opioid labeling opioid drugs pediatric prescriptions develop recommendations education programs prescribers opioids issue guidance labeling opioid abuse bill amends federal food drug cosmetic act requiring manufacturers opioid drugs ensure certain information risk factors associated opioid drugs included drug labels bill amends controlled substances act addressing annual narcotic manufacturing quotas respect fentanyl hydrocodone directing department_of_justice doj require medical practitioners complete training program prescribing opioids chronic pain certified prescribe controlled substances schedule iii bill establishes requirements prescription drug monitoring systems prevent prescribing controlled substances department_of_health_and_human_services submit plan action addressing opioid prescribing practices ensuring adequate response protect public health study expansion medicare coverage alternatives opioid treatments bill amends_the_internal_revenue_code impose excise tax manufacturers producers opioid pain portion generated tax substance abuse treatment programs doj establish program safe environmentally responsible disposal controlled substances


Summary:
Helping Our Veterans with Chronic Pain and Opioid Addiction Act of 2016

This bill requires the Department of Veterans Affairs (VA) to conduct a three-year pilot program to provide health and social services and coordination of care and case management to covered veterans in need of treatment for opioid addiction and chronic pain through VA facilities and through qualified non-VA health care providers.

A "covered veteran" is a veteran who is enrolled in the veterans' health care system and eligible for hospital, nursing home, and domiciliary care under such system.

The pilot program shall be carried out in at least five different states with VA medical facilities that demonstrate: (1) the need for additional resources to provide health care services to veterans for opioid abuse, (2) the highest rates per capita of opioid addiction in the United States, and (3) a lack of sufficient VA capacity to meet the demand for such treatment.

Under such program, the VA: (1) may enter into contracts with non-VA providers to provide health care services to veterans,  and (2) shall provide for the exchange of medical information between the VA and any such provider.

The VA shall conduct concurrent assessments of its capabilities and the capabilities of community providers to provide health care services for the treatment of veterans with opioid dependency abuse or chronic pain.

The VA shall: (1) require all appropriate VA health care facilities and all VA facilities providing mental health and social services to veterans to have a supply of naloxone or other medication for reversing opioid overdose, and (2) ensure that all appropriate employees at such facilities receive training on the administration of such medication.

helping veterans chronic pain opioid addiction act bill requires department_of_veterans_affairs conduct year pilot program provide health social_services coordination care case management covered veterans need treatment opioid addiction chronic pain facilities qualified non-va health_care providers covered veteran veteran enrolled veterans health_care system eligible hospital nursing home domiciliary care system pilot program shall carried different states medical facilities demonstrate need additional resources provide health_care services veterans opioid abuse highest rates capita opioid addiction united_states lack sufficient capacity meet demand treatment program enter contracts non-va providers provide health_care services veterans shall provide exchange medical information provider shall conduct concurrent assessments capabilities capabilities community providers provide health_care services treatment veterans opioid dependency abuse chronic pain shall require appropriate health_care facilities facilities providing mental health social_services veterans supply naloxone medication opioid overdose ensure appropriate employees facilities receive training administration medication


Summary:
Youth Opioid Use Treatment Help Act of 2016 or the YOUTH Act

This bill amends the Public Health Service Act to revise and reauthorize through FY2022 grants for substance abuse treatment services for children and adolescents. The grant program is expanded to cover young adults.

The Agency for Healthcare Research and Quality (AHRQ) must award grants for demonstration programs to: (1) expand access to medication-assisted treatment for opioid use disorders among adolescents and young adults, or (2) create and distribute for pediatric health care providers resources on medication-assisted treatment training and implementation.

AHRQ must report on the demonstration programs and the availability of medication-assisted treatment for adolescents and young adults. The report must include recommendations for ensuring such treatment is accessible.

The Government Accountability Office must study how federal agencies are addressing substance use and substance use disorders among adolescents and young adults.

youth opioid use treatment help act youth act bill amends public_health_service_act revise reauthorize fy2022 grants substance abuse treatment services children adolescents grant program expanded cover young adults agency healthcare_research_and_quality ahrq award grants demonstration programs expand access medication assisted treatment opioid use disorders adolescents young adults create distribute pediatric health_care providers resources medication assisted treatment training implementation ahrq report demonstration programs availability medication assisted treatment adolescents young adults report include recommendations ensuring treatment accessible government_accountability_office study federal agencies addressing substance use substance use disorders adolescents young adults


Summary:
Comprehensive Fentanyl Control Act

This bill amends the Controlled Substances Act (CSA) to modify the definition of "controlled substance analogue" to mean a substance that has a similar (previously, substantially similar) chemical structure and pharmacological effect to a schedule I controlled substance.

 Additionally, it modifies the treatment of controlled substance analogues. Under current law, a controlled substance analogue that is intended for human consumption is treated as a schedule I controlled substance. This bill replaces the "intended for human consumption" qualifier with a "not a chemical substance subject to the Toxic Substances Control Act" qualifier. Specifically, a controlled substance analogue that is not a chemical substance under the Toxic Substances Control Act is treated as a schedule I controlled substance.

 The bill modifies the drug quantity thresholds that trigger a mandatory minimum prison term for a defendant who manufactures, distributes, or possesses with intent to distribute fentanyl.

It also establishes a consecutive mandatory prison term for a defendant who commits a drug offense involving a detectable amount of heroin or fentanyl.

The bill allows the Drug Enforcement Administration to temporarily place a substance into schedule I if it reasonably believes that the substance: (1) is a synthetic opioid analgesic; (2) is the object of clandestine importation, manufacture, or distribution; and (3) poses an imminent hazard to public health and safety. Finally, the bill makes it a crime to knowingly mail to an unauthorized person equipment that may be used to manufacture counterfeit controlled substances.

comprehensive fentanyl control act bill amends controlled substances act csa modify definition controlled substance analogue mean substance similar previously substantially similar chemical structure pharmacological effect schedule controlled substance additionally modifies treatment controlled substance current law controlled substance analogue intended human consumption treated schedule controlled substance bill replaces intended human consumption chemical substance subject toxic_substances_control_act specifically controlled substance analogue chemical substance toxic_substances_control_act treated schedule controlled substance bill modifies drug quantity thresholds trigger mandatory minimum prison term defendant manufactures distributes possesses intent distribute fentanyl establishes consecutive mandatory prison term defendant commits drug offense involving detectable heroin fentanyl bill allows drug_enforcement_administration temporarily place substance schedule reasonably believes substance synthetic opioid analgesic object clandestine importation manufacture distribution poses imminent hazard public health safety finally bill makes crime knowingly mail unauthorized person equipment manufacture counterfeit controlled substances


Summary:
Addiction Recovery through Family Health Accounts Act

This bill amends the Internal Revenue Code to permit taxpayers to use tax-favored health reimbursement arrangements, health flexible spending arrangements, health savings accounts, and Archer medical savings accounts to pay for alcohol and drug addiction treatments for specified family members as if the expenses were incurred for a dependent.

addiction recovery family health accounts act bill amends_the_internal_revenue_code permit taxpayers use tax favored health reimbursement arrangements health flexible spending arrangements health savings_accounts archer_medical_savings_accounts pay alcohol drug addiction treatments specified family members expenses incurred dependent


Summary:
Addiction Recovery through Family Deductions Act

This bill amends the Internal Revenue Code to expand certain deductions and exclusions to include expenses related to alcohol and drug addiction treatments for specified family members who are not dependents.

The bill allows the expenses to be treated as: (1) medical care for the purpose of the deduction for medical care, and (2) qualified Indian health care benefits for the purpose of the exclusion from gross income of the value of any qualified Indian health care benefit.

The bill also allows insurance covering alcohol and drug addiction treatment for the non-dependent family members to be treated as insurance that constitutes medical care for the purpose of the deduction for health-insurance costs of self-employed individuals.

addiction recovery family deductions act bill amends_the_internal_revenue_code expand certain deductions exclusions include expenses related alcohol drug addiction treatments specified family members dependents bill allows expenses treated medical care purpose deduction medical care qualified indian health_care benefits purpose exclusion gross income value qualified indian health_care benefit bill allows insurance covering alcohol drug addiction treatment non dependent family members treated insurance constitutes medical care purpose deduction health insurance costs self employed individuals


Summary:
National All Schedules Prescription Electronic Reporting Reauthorization Act of 2016

 (Sec. 3) This bill amends the Public Health Service Act to revise and extend through FY2021 the controlled substance monitoring program, including to:

 allow grants to be used to maintain existing state controlled substance monitoring programs; require the Department of Health and Human Services (HHS) to redistribute any funds that are returned among the remaining grantees; require states to report on the interoperability of their programs with federal programs and health information technology systems and whether their programs provide automatic, up-to-date, or daily information about a patient upon request; require states to provide HHS with aggregate data and other information to enable HHS to evaluate the success of state programs; and expand the program to include any commonwealth or territory of the United States. The Drug Enforcement Administration, HHS, a state Medicaid program, a state health department, or a state substance abuse agency receiving nonidentifiable information from a controlled substance monitoring database for research purposes may make that information available to other entities for research purposes.

HHS is no longer required to give preference for grants related to drug abuse to states with controlled substance monitoring programs.

 A state receiving a grant for a controlled substance monitoring program must: (1) facilitate prescriber and dispenser use of the controlled substance monitoring system, and (2) educate prescribers and dispensers on the benefits of the system.

national schedules prescription electronic reporting reauthorization act sec bill amends public_health_service_act revise extend fy2021 controlled substance monitoring program including allow grants maintain existing state controlled substance monitoring programs require department_of_health_and_human_services hhs redistribute funds returned remaining grantees require states report interoperability programs federal programs health information technology systems programs provide automatic date daily information patient request require states provide hhs aggregate data information enable hhs evaluate success state programs expand program include commonwealth territory united_states drug_enforcement_administration hhs state medicaid program state health department state substance abuse agency receiving information controlled substance monitoring database research purposes information available entities research purposes hhs longer required preference grants related drug abuse states controlled substance monitoring programs state receiving grant controlled substance monitoring program facilitate prescriber dispenser use controlled substance monitoring system educate prescribers dispensers benefits system


Summary:
Increasing the Safety of Prescription Drug Use Act of 2015

This bill amends the Public Health Service Act to revise, update, and expand state controlled substance monitoring programs, which ensure that prescription history information is accessible for investigations into drug diversion and errant prescribing and dispensing practices.

A state's controlled substance monitoring program database must be interoperable with other states' databases and electronic health records, and must provide up-to-date patient information to practitioners. Practitioners and dispensers are required to use the database.

Database information cannot be used to conduct a criminal investigation against a patient. Certain entities are allowed to make nonidentifiable information from a database available for research.

Federal health care workers must screen patients for abuse of controlled substances, conduct brief interventions, and provide referrals for known or suspected abuse of controlled substances.

Grants are established for: (1) a pilot project to develop a peer review process to evaluate prescribing and pharmacy dispensing patterns, (2) training health care providers to prevent controlled substance abuse, (3) evaluating the prospect of health professions boards reviewing the prescribing authorities of providers, and (4) developing criteria and processes that allow health professions boards or state agencies to certify education and training for informed and safe prescribing of certain controlled substances.

Practitioners who register or renew a registration with the Drug Enforcement Administration to dispense or conduct research with controlled substances must have completed specified continuing medical education. A registered practitioner must screen patients for drug abuse before prescribing certain controlled substances.

The Food and Drug Administration must consider whether naloxone (a drug used to rapidly reverse overdoses of heroin and other opiods) should be a behind-the-counter drug instead of a prescription drug.

This bill amends the Controlled Substances Act to increase the number of patients a practitioner is allowed to treat by dispensing narcotic drugs for maintenance or detoxification.

increasing safety prescription drug use act bill amends public_health_service_act revise update expand state controlled substance monitoring programs ensure prescription history information accessible investigations drug diversion prescribing dispensing practices state controlled substance monitoring program database interoperable states databases electronic health records provide date patient information practitioners practitioners dispensers required use database database information conduct criminal investigation patient certain entities allowed information database available research federal health_care workers screen patients abuse controlled substances conduct brief interventions provide referrals known suspected abuse controlled substances grants established pilot project develop peer_review process evaluate prescribing pharmacy dispensing patterns training health_care providers prevent controlled substance abuse evaluating health professions boards reviewing prescribing authorities providers developing criteria processes allow health professions boards state agencies certify education training informed safe prescribing certain controlled substances practitioners register renew registration drug_enforcement_administration dispense conduct research controlled substances completed specified continuing medical education registered practitioner screen patients drug abuse prescribing certain controlled substances food_and_drug_administration consider naloxone drug rapidly reverse heroin counter drug instead prescription drug bill amends controlled substances act increase number patients practitioner allowed treat dispensing narcotic drugs maintenance detoxification


Summary:
Opioid Overdose Reduction Act of 2015

This bill exempts individuals from liability for harm caused by the emergency administration of an opioid overdose drug under certain circumstances. (An opioid is a drug with effects similar to opium, such as heroin.) The individuals exempted from liability are:

 a health care professional who prescribes or provides an opioid overdose drug to an individual at risk of experiencing an opioid overdose or to another individual in a position to assist an at-risk individual, if the individual prescribed or provided the drug has been educated about opioid overdose prevention and treatment by the health care professional or as part of a government opioid overdose program; an individual who provides an opioid overdose drug for emergency administration to another individual authorized to receive it as part of an opioid overdose program; and an individual who administers an opioid overdose drug to another individual who appears to have suffered an opioid overdose if the administering individual obtained the drug from a health care professional or as part of an opioid overdose program and was educated by the professional or program in the proper administration of the drug. These exemptions are inapplicable if the harm was caused by gross negligence or reckless misconduct.

States can preempt these exemptions by providing additional protections from liability for individuals that administer opioid overdose drugs, or by enacting legislation making this Act not applicable to state civil action involving only citizens from that state.

opioid overdose reduction act bill exempts individuals liability harm caused emergency administration opioid overdose drug certain circumstances opioid drug effects similar opium heroin individuals exempted liability health_care professional prescribes provides opioid overdose drug individual risk experiencing opioid overdose individual position assist risk individual individual prescribed provided drug educated opioid overdose prevention treatment health_care professional government opioid overdose program individual provides opioid overdose drug emergency administration individual authorized receive opioid overdose program individual administers opioid overdose drug individual appears suffered opioid overdose administering individual obtained drug health_care professional opioid overdose program educated professional program proper administration drug exemptions inapplicable harm caused gross negligence reckless misconduct states preempt exemptions providing additional protections liability individuals administer opioid overdose drugs enacting legislation making act applicable state civil action involving citizens state


Summary:
Sober Truth on Preventing Underage Drinking Reauthorization Act or the STOP Act

Amends the Public Health Service Act to reauthorize the program to reduce underage drinking for FY2016-FY2019.

Revises reporting requirements for state programs on underage drinking.

 Specifies additional requirements for the development of the national media campaign to prevent underage drinking.

Directs the Substance Abuse and Mental Health Services Administration to make grants to professional pediatric provider organizations to increase effective practices, including the screening of children and adolescents for alcohol use, to reduce the prevalence of alcohol use among individuals under the age of 21, including college students.

Directs the Department of Health and Human Services to collect data and conduct or support new research on underage drinking that carries out and improves public health surveillance of alcohol use and alcohol-related conditions in states among individuals between age 18 and 20 by increasing the use of surveys, such as the Behavioral Risk Factor Surveillance System, to monitor binge and excessive drinking and related harms.

Amends the Federal Alcohol Administration Act to prohibit the manufacture, sale, distribution, or possession of powdered alcohol.

truth preventing drinking reauthorization act stop act amends public_health_service_act reauthorize program reduce drinking fy2016 fy2019 revises reporting requirements state programs drinking specifies additional requirements development national media campaign prevent drinking directs substance_abuse_and_mental_health_services_administration grants professional pediatric provider organizations increase effective practices including screening children adolescents alcohol use reduce prevalence alcohol use individuals age including college students directs_the_department_of_health_and_human_services collect data conduct support new research drinking carries improves public health surveillance alcohol use alcohol related conditions states individuals age increasing use surveys behavioral risk factor surveillance system monitor excessive drinking related harms amends federal alcohol administration act prohibit manufacture sale distribution possession alcohol


Summary:
Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2015

This bill requires the Department of Health and Human Services (HHS), in cooperation with the Department of Veterans Affairs, the Department of Defense, and the Drug Enforcement Administration, to convene a Pain Management Best Practices Inter-Agency Task Force to develop and study best practices for pain management and prescription of pain medication.

The Harold Rogers Prescription Drug Monitoring Program is extended through FY2020. The Government Accountability Office must evaluate the effectiveness of this program in reducing prescription drug abuse and any corresponding increase or decrease in the use of heroin.

This bill amends the Omnibus Crime Control and Safe Streets Act of 1968 to extend the Edward Byrne Memorial Justice Assistance Grant Program through FY2020.

HHS must advance education and awareness of the risk of abuse of prescription opioids (drugs with effects similar to opium).

The Office of National Drug Control Policy (ONDCP), in coordination with HHS and the Department of Justice (DOJ), must establish a national drug awareness campaign that emphasizes the similarities between heroin and prescription opioids and increases awareness of the dangerous effects of mixing fentanyl (a prescription opioid painkiller) with heroin.

DOJ, in coordination with HHS and ONDCP, may make grants to state, local, or tribal governments to create demonstration programs to allow first responders to prevent opioid overdose death by administering an opioid overdose reversal drug (e.g., naloxone). Priority must be given to entities in states that provide civil liability protection for first responders administering a drug to counteract opioid overdoses.

heroin prescription opioid abuse prevention education enforcement act bill requires department_of_health_and_human_services hhs cooperation department_of_veterans_affairs department_of_defense drug_enforcement_administration convene pain management best practices inter agency task_force develop study best practices pain management prescription pain medication harold rogers prescription drug monitoring program extended fy2020 government_accountability_office evaluate effectiveness program reducing prescription drug abuse corresponding increase decrease use heroin bill amends omnibus_crime_control_and_safe_streets_act extend edward_byrne_memorial_justice assistance grant program fy2020 hhs advance education awareness risk abuse prescription opioids drugs effects similar opium office_of_national_drug_control_policy coordination hhs department_of_justice doj establish national drug awareness campaign emphasizes similarities heroin prescription opioids increases awareness dangerous effects fentanyl prescription opioid heroin doj coordination hhs grants state local tribal governments create demonstration programs allow responders prevent opioid overdose death administering opioid overdose reversal drug naloxone priority given entities states provide civil liability protection responders administering drug opioid


Summary:
Treatment and Recovery Investment Act

This bill amends the Public Health Service Act to authorize the Center for Substance Abuse Treatment to award grants to state agencies responsible for administering funds received under the substance abuse prevention and treatment block grant program, to local governments that have a high rate of, or have had a rapid increase in, the use of, or death related to the use of, heroin or other opioids (including prescription opioids), and to Indian tribes or tribal organizations in order to permit such entities to expand evidence-based treatment activities and related recovery services.

The Center shall award: (1) five-year grants to state substance abuse agencies, Indian tribes or tribal organizations, and public nonprofit entities to enhance access to primary care and related services for pregnant and parenting women diagnosed with opioid dependence; and (2) grants, contracts, or cooperative agreements of up to five years duration to eligible state substance abuse agencies and other appropriate entities to increase the capacity of substance use disorder treatment and recovery services for adolescents.

The Substance Abuse and Mental Health Services Administration shall award grants to state substance abuse agencies and non-profit organizations to develop, expand, and enhance recovery support services for individuals with substance use disorders.

The amount authorized under the substance abuse prevention and treatment block grant program is increased: (1) to a specified amount for FY2016, and (2) by the annual percentage increase in the Consumer Price Index for each subsequent year.

The Comptroller General shall evaluate and report on the in-patient and outpatient treatment capacity, availability, and needs of the United States.

treatment recovery investment act bill amends public_health_service_act authorize center_for_substance_abuse_treatment award grants state agencies responsible administering funds received substance abuse prevention treatment block grant program local governments high rate rapid increase use death related use heroin opioids including prescription opioids indian tribes tribal organizations order permit entities expand evidence based treatment activities related recovery services center shall award year grants state substance abuse agencies indian tribes tribal organizations public nonprofit entities enhance access primary care related services pregnant parenting women diagnosed opioid dependence grants contracts cooperative agreements years duration eligible state substance abuse agencies appropriate entities increase capacity substance use disorder treatment recovery services adolescents substance_abuse_and_mental_health_services_administration shall award grants state substance abuse agencies non profit organizations develop expand enhance recovery support services individuals substance use disorders authorized substance abuse prevention treatment block grant program increased specified fy2016 annual percentage increase consumer price index subsequent year comptroller_general shall evaluate report patient outpatient treatment capacity availability needs united_states


Summary:
Prescription Drug Abuse Prevention and Treatment Act of 2015

This bill amends the Public Health Service Act to require the Substance Abuse and Mental Health Services Administration (SAMHSA) to award grants for consumer education about opioid abuse. (Opioids are drugs with effects similar to opium, such as heroin or certain prescription painkillers.)

This bill amends the Controlled Substances Act to require medical practitioners to be trained in the treatment of opioid-dependent patients, pain management, and early detection of opioid addiction before they can be registered by the Drug Enforcement Administration to dispense opioids.

Opioid treatment programs that close on any day must make arrangements for each patient to receive treatment during the closure, as necessary.

A report must be submitted to SAMHSA for each individual who dies while receiving treatment in an opioid treatment program. In states receiving funding for controlled substance monitoring programs, deaths where an opioid drug is detected in the body must be reported to SAMHSA.

The National Center for Health Statistics of the Centers for Disease Control and Prevention must establish a National Opioid Death Registry to track opioid-related deaths.

The Agency for Healthcare Research and Quality must develop and apply prescription drug abuse prevention and treatment quality measures.

This bill amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to allow prescription drug plan (PDP) sponsors to limit the access of certain beneficiaries to frequently abused drugs. PDP sponsors must have a utilization management tool to prevent drug abuse.

Medicare Drug Integrity Contractors may accept prescription and medical records to determine whether a beneficiary is at risk for prescription drug abuse.

prescription drug abuse prevention treatment act bill amends public_health_service_act require substance_abuse_and_mental_health_services_administration samhsa award grants consumer education opioid abuse opioids drugs effects similar opium heroin certain prescription bill amends controlled substances act require medical practitioners trained treatment opioid dependent patients pain management early detection opioid addiction registered drug_enforcement_administration dispense opioids opioid treatment programs close day arrangements patient receive treatment closure necessary report submitted samhsa individual dies receiving treatment opioid treatment program states receiving funding controlled substance monitoring programs deaths opioid drug detected body reported samhsa national_center_for_health_statistics centers_for_disease_control_and_prevention establish national opioid death registry track opioid related deaths agency healthcare_research_and_quality develop apply prescription drug abuse prevention treatment quality measures bill amends voluntary prescription drug benefit program title xviii medicare social_security_act allow prescription drug plan pdp sponsors limit access certain beneficiaries frequently abused drugs pdp sponsors utilization management tool prevent drug abuse medicare drug integrity contractors accept prescription medical records determine beneficiary risk prescription drug abuse


Summary:
Overdose Prevention Act

This bill amends the Public Health Service Act to require the Substance Abuse and Mental Health Services Administration (SAMHSA) to enter into cooperative agreements to reduce deaths from drug overdoses by: (1) purchasing and distributing naloxone (a medication that rapidly reverses overdose from heroin or other drugs with effects similar to opium) or a similar drug; and (2) educating or training the public, first responders, or health professionals on drug overdose prevention or response.

SAMHSA must establish a coordinating center and develop a plan to reduce drug overdose deaths by educating the public about overdose prevention and recommending improvements to overdose prevention programs.

The Centers for Disease Control and Prevention must improve drug overdose surveillance by entering into cooperative agreements to: (1) provide training to improve identification of drug overdose as the cause of death, and (2) establish a national program for reporting drug overdoses.

The National Institute on Drug Abuse (NIDA) must prioritize, conduct, and support research on circumstances that contribute to drug overdose, drugs associated with fatal overdose, and overdose prevention methods. NIDA must support research on drug overdose treatments that can be administered by lay persons or first responders.

overdose prevention act bill amends public_health_service_act require substance_abuse_and_mental_health_services_administration samhsa enter cooperative agreements reduce deaths drug purchasing distributing naloxone medication rapidly reverses overdose heroin drugs effects similar opium similar drug educating training public responders health professionals drug overdose prevention response samhsa establish coordinating center develop plan reduce drug overdose deaths educating public overdose prevention recommending improvements overdose prevention programs centers_for_disease_control_and_prevention improve drug overdose surveillance entering cooperative agreements provide training improve identification drug overdose cause death establish national program reporting drug national institute drug abuse prioritize conduct support research circumstances contribute drug overdose drugs associated fatal overdose overdose prevention methods support research drug overdose treatments administered lay persons responders


Summary:
Stopping Medication Abuse and Protecting Seniors Act of 2015

This bill amends title XVIII (Medicare) of the Social Security Act to: (1) authorize a Medicare prescription drug plan (PDP) sponsor to establish a drug management program under which the PDP sponsor may limit an at-risk beneficiary’s access to coverage for frequently abused drugs to include only those drugs that are prescribed by selected prescribers and dispensed by selected pharmacies; and (2) require a PDP sponsor to have in place a utilization management tool to prevent drug abuse.

With respect to a drug management program, a PDP sponsor must: (1) provide specified notice to a beneficiary who has been identified by the Centers for Medicare & Medicaid (CMS) as “at-risk” and consequently enrolled in the program; and (2) in selecting prescribers and dispensers, ensure that the beneficiary continues to have reasonable access to drugs. These determinations shall be subject to expedited reconsideration and appeal. A PDP sponsor must review and consider an at-risk beneficiary’s preferences regarding prescriber and pharmacy selection.

Certain individuals, including those receiving hospice care or residing in a long-term care facility, are exempted from enrollment in a drug management program.

CMS must, for purposes of quality or performance assessments, review and consider complaints received from at-risk beneficiaries regarding lack of access due to their enrollment in a drug management program. In addition, CMS must establish rules and procedures requiring a PDP sponsor to provide specified program data.

stopping medication abuse protecting seniors act bill amends title xviii medicare social_security_act authorize medicare_prescription_drug plan pdp sponsor establish drug management program pdp sponsor limit risk beneficiary access coverage frequently abused drugs include drugs prescribed selected prescribers dispensed selected pharmacies require pdp sponsor place utilization management tool prevent drug abuse respect drug management program pdp sponsor provide specified notice beneficiary identified centers medicare medicaid cms risk enrolled program selecting prescribers dispensers ensure beneficiary continues reasonable access drugs determinations shall subject expedited reconsideration appeal pdp sponsor review consider risk beneficiary preferences prescriber pharmacy selection certain individuals including receiving hospice care residing long-term_care facility exempted enrollment drug management program cms purposes quality performance assessments review consider complaints received risk beneficiaries lack access enrollment drug management program addition cms establish rules procedures requiring pdp sponsor provide specified program data


Summary:
Combat Heroin Epidemic and Backlog Act of 2015

This bill amends the Omnibus Crime Control and Safe Streets Act of 1968 to authorize the Department of Justice's Bureau of Justice Assistance to award grants to state and tribal governments to address the distribution, sale, and use of heroin, fentanyl, and associated synthetic drugs.

 Grants may be used to:

 reimburse forensic science laboratories for efforts to address and prevent testing backlogs; reimburse law enforcement agencies for equipment to identify or detect heroin, fentanyl, and associated synthetic drugs; investigate, arrest, and prosecute distributors or sellers; and support health department services for users.

combat heroin epidemic backlog act bill amends omnibus_crime_control_and_safe_streets_act authorize department_of_justice bureau_of_justice_assistance award grants state tribal governments address distribution sale use heroin fentanyl associated synthetic drugs grants reimburse forensic science laboratories efforts address prevent testing backlogs reimburse law enforcement agencies equipment identify detect heroin fentanyl associated synthetic drugs investigate arrest prosecute distributors sellers support health department services users


Summary:
This bill provides FY2016 supplemental appropriations for the Department of Justice (DOJ) and the Department of Health and Human Services (HHS) to address heroin and opioid drug abuse. The funds are designated as an emergency requirement, which exempts the funds from discretionary spending limits and other budget enforcement rules.

For DOJ, the bill provides funds for State and Local Law Enforcement Assistance and Community Oriented Policing Services (COPS) programs.

For HHS, the bill provides funds for:

 the Substance Abuse and Mental Health Services Administration, the Centers for Disease Control and Prevention, the National Institutes of Health, and the Public Health and Social Services Emergency Fund.

bill provides fy2016 supplemental appropriations department_of_justice doj department_of_health_and_human_services hhs address heroin opioid drug abuse funds designated emergency requirement exempts funds discretionary spending limits budget enforcement rules doj bill provides funds state local law enforcement assistance community oriented policing services cops programs hhs bill provides funds substance_abuse_and_mental_health_services_administration centers_for_disease_control_and_prevention national_institutes_of_health public health social_services emergency fund


Summary:
Heroin and Prescription Drug Abuse Prevention and Reduction Act

This bill amends the Controlled Substances Act to revise requirements for and limitations on practitioners who dispense narcotic drugs for maintenance or detoxification treatment.

The Department of Health and Human Services (HHS) must establish grant programs to: (1) encourage prescribing and purchase of opioid overdose reversal drugs (e.g., naloxone), and (2) develop prescribing guidelines for such drugs. (Opioids are drugs with effects similar to opium, such as heroin or certain pain medications.)

The Centers for Disease Control and Prevention must provide support to improve drug overdose surveillance and reporting capabilities.

HHS may support syringe exchange programs.

The Substance Abuse and Mental Health Services Administration must provide support to reduce drug overdose deaths.

This bill amends the Public Health Service Act to extend residential treatment programs for pregnant and postpartum women.

HHS must: (1) carry out a pilot program to support services for pregnant and postpartum women with a substance use disorder; (2) award grants to expand treatment activities in areas with a high rate of, or a rapid increase in, the use of opioids; (3) support increasing the capacity of substance use disorder services for adolescents; and (4) develop, expand, and enhance substance use recovery support services.

This bill amends the Employee Retirement Income Security Act of 1974 (ERISA) and Internal Revenue Code to direct HHS and the Departments of Labor and the Treasury to require disclosures, issue guidance, conduct audits, and publish information regarding the requirement for group health plans and health insurance coverage to have parity between mental health and substance use disorder benefits and medical and surgical benefits. HHS must establish a consumer parity portal website.

HHS must establish a loan repayment program for substance use disorder health professionals.

heroin prescription drug abuse prevention reduction act bill amends controlled substances act revise requirements limitations practitioners dispense narcotic drugs maintenance detoxification treatment department_of_health_and_human_services hhs establish grant programs encourage prescribing purchase opioid overdose reversal drugs naloxone develop prescribing guidelines drugs opioids drugs effects similar opium heroin certain pain medications centers_for_disease_control_and_prevention provide support improve drug overdose surveillance reporting capabilities hhs support exchange programs substance_abuse_and_mental_health_services_administration provide support reduce drug overdose deaths bill amends public_health_service_act extend residential treatment programs pregnant postpartum women hhs carry pilot program support services pregnant postpartum women substance use disorder award grants expand treatment activities areas high rate rapid increase use opioids support increasing capacity substance use disorder services adolescents develop expand enhance substance use recovery support services bill amends employee retirement income security act erisa internal_revenue_code direct hhs departments_of_labor treasury require disclosures issue guidance conduct audits publish information requirement group health plans health insurance coverage parity mental health substance use disorder benefits medical surgical benefits hhs establish consumer parity portal website hhs establish loan repayment program substance use disorder health professionals


Summary:
Medicaid Coverage for Addiction Recovery Expansion Act

This bill amends title XIX (Medicaid) of the Social Security Act to allow states to provide medical assistance to adults for residential addiction treatment facility services under the Medicaid program. "Residential addiction treatment facility services" are medically necessary inpatient services provided in an accredited, size-limited facility for the purpose of treating a substance use disorder within a specified time period.

The provision of medical assistance for such services to an individual shall not prohibit federal financial participation for medical assistance with respect to other services provided to the individual within the same time period.

Subject to specified conditions, a woman who is eligible for medical assistance on the basis of being pregnant may remain eligible for residential addiction treatment facility services for specified time periods without regard to eligibility limits that would otherwise apply as a result of her pregnancy ending.

In addition, the bill establishes a grant program for states to expand infrastructure and treatment capabilities of existing youth addiction treatment facilities that: (1) provide addiction treatment services to youths under Medicaid or the Children's Health Insurance Program (CHIP), and (2) are located in communities with high numbers of medically underserved populations of at-risk youths. At least 15% of grant funds awarded to a state must be used for making payments to rural facilities.

medicaid coverage addiction recovery expansion act bill amends title xix medicaid social_security_act allow states provide medical assistance adults residential addiction treatment facility services medicaid program residential addiction treatment facility services medically necessary inpatient services provided accredited size limited facility purpose treating substance use disorder specified time period provision medical assistance services individual shall prohibit federal financial participation medical assistance respect services provided individual time period subject specified conditions woman eligible medical assistance basis pregnant remain eligible residential addiction treatment facility services specified time periods regard eligibility limits apply result pregnancy ending addition bill establishes grant program states expand infrastructure treatment capabilities existing youth addiction treatment facilities provide addiction treatment services youths medicaid children health insurance program chip located communities high numbers medically underserved populations risk youths grant funds awarded state making payments rural facilities


Summary: Public Housing Tenants Respect Act of 2007 - Amends the United States Housing Act of 1937 to repeal its public housing community service and family self-sufficiency requirements.

public housing tenants respect act amends united_states_housing_act repeal public housing community service family self sufficiency requirements


Summary: Brownfields Redevelopment Enhancement Act - Amends the Housing and Community Development Act of 1974 to authorize the Secretary of Housing and Urban Development to make grants (without certain otherwise-required loan guarantees) to eligible public entities and Indian tribes to assist in the environmental cleanup and economic development of brownfield sites including mine-scarred lands. Prohibits: (1) providing or using such grants in a manner that reduces the financial responsibility of any nongovernmental party that is responsible or potentially responsible for contamination on any real property; and (2) the provision of assistance pursuant to this section from in any way relieving any party of liability with respect to such contamination, including liability for removal and remediation costs. Authorizes FY2008-FY2012 appropriations. Defines "brownfield site" for purposes of this Act. Makes brownfields-related environmental cleanup and economic development activities eligible for community development block grant (CDBG) assistance. Authorizes CDBG use to administer renewal communities.

brownfields redevelopment enhancement act_-_amends housing_and_community_development_act authorize secretary housing_and_urban_development grants certain required loan guarantees eligible public entities indian tribes assist environmental cleanup economic development brownfield sites including lands prohibits providing grants manner reduces financial responsibility nongovernmental party responsible potentially responsible contamination real property provision assistance pursuant section way relieving party liability respect contamination including liability removal remediation costs authorizes fy2008 fy2012 appropriations defines brownfield site purposes act makes brownfields related environmental cleanup economic development activities eligible community development block grant cdbg assistance authorizes cdbg use administer renewal communities


Summary: Mark-to-Market Extension Act of 2007 - Amends the Multifamily Assisted Housing Reform and Affordability Act of 1997 to reauthorize through FY2011: (1) the Federal Housing Administration (FHA)-insured Multifamily Housing Mortgage and Housing Assistance Restructuring (Mark-to-Market) program; and (2) the Office of Multifamily Housing Assistance Restructuring. Permits the Secretary of Housing and Urban Development to waive rent level limits for: (1) disaster-damaged eligible projects; and (2) up to 9% (currently 5%) of all units subject to restructured mortgages in any fiscal year, based on certain findings of special need. Redefines multifamily housing project eligible for the Mark-to-Market program to authorize eligibility treatment, upon owner request, for certain projects whose rents do not, on an average per unit or per room basis, exceed the rent of comparable properties in the same market area, if the Secretary determines that such treatment is necessary to preserve a project in the most cost-effective manner in relation to other alternative preservation options. Requires each mortgage restructuring and rental assistance sufficiency plan to determine, for units assisted with project-based assistance in eligible multifamily housing projects, adjusted rent levels for disaster-damaged eligible projects equal to 100% of the fair market rents for the relevant market area. Revises requirements for an approved mortgage restructuring and rental assistance sufficiency plan with respect to modification or forgiveness of all or part of a second mortgage held by the Secretary (debt relief) if the project concerned is acquired by a tenant organization or tenant-endorsed community-based nonprofit or public agency. Sets forth requirements for alternative periods of eligibility for such nonprofit debt relief if the purchaser acquires the project subsequent to the date of recordation of the related affordability agreement.

mark market extension act amends multifamily assisted housing reform affordability act reauthorize fy2011 federal_housing_administration multifamily housing mortgage housing assistance restructuring mark market program office multifamily housing assistance restructuring permits secretary housing_and_urban_development waive rent level limits disaster damaged eligible projects currently units subject restructured mortgages fiscal year based certain findings special need redefines multifamily housing project eligible mark market program authorize eligibility treatment owner request certain projects rents average unit room basis exceed rent comparable properties market area secretary determines treatment necessary preserve project cost effective manner relation alternative preservation options requires mortgage restructuring rental assistance sufficiency plan determine units assisted project based assistance eligible multifamily housing projects adjusted rent levels disaster damaged eligible projects equal fair market rents relevant market area revises requirements approved mortgage restructuring rental assistance sufficiency plan respect modification forgiveness second mortgage held secretary debt relief project concerned acquired tenant organization tenant endorsed community based nonprofit public agency sets forth requirements alternative periods eligibility nonprofit debt relief purchaser acquires project subsequent date recordation related affordability agreement


Summary: Heritage Homes Tax Incentive Act of 2007 - Amends the Internal Revenue Code to grant a tax deduction (whether or not the taxpayer itemizes deductions) for 125 percent of residence interest paid or accrued on acquisition indebtedness for heritage homes. Defines a "heritage home" as a taxpayer's principal residence that is at least 50 years old and a certified historic structure in a registered historic district.

heritage homes tax incentive act amends_the_internal_revenue_code grant tax deduction taxpayer itemizes deductions percent residence interest paid accrued acquisition indebtedness heritage homes defines heritage home taxpayer principal residence years old certified historic structure registered historic district


Summary: American Homebuyers Protection Act - Prohibits a person engaged in the construction of new homes from: (1) requiring a home purchaser to enter into a mandatory arbitration agreement as a condition precedent to entering into a purchase contract; and (2) offering a home purchaser a contract which includes a mandatory arbitration agreement unless such agreement is a separate agreement. Treats a violation as as an unfair and deceptive act under the Federal Trade Commission Act.

american homebuyers protection act prohibits person engaged construction new homes requiring home purchaser enter mandatory arbitration agreement condition precedent entering purchase contract offering home purchaser contract includes mandatory arbitration agreement agreement separate agreement treats violation unfair deceptive act federal_trade_commission_act


Summary: Fire Sprinkler Incentive Act of 2007 - Amends the Internal Revenue Code to classify automatic fire sprinkler systems as five-year depreciable property. Makes this Act applicable to property placed in service after April 11, 2003.

fire sprinkler incentive act amends_the_internal_revenue_code classify automatic fire sprinkler systems year depreciable property makes act applicable property placed service april


Summary: Corrosion Prevention Act of 2007 - Amends the Internal Revenue Code to allow a business-related tax credit for 50% of net expenditures for engineering design, materials, and application and installation of corrosion prevention and mitigation technology for depreciable property comprised primarily of metals susceptible to corrosion. Terminates such credit after 2017.

corrosion prevention act amends_the_internal_revenue_code allow business related tax credit net expenditures engineering design materials application installation corrosion prevention mitigation technology depreciable property comprised primarily metals susceptible corrosion terminates credit


Summary: Rural Housing and Economic Development Improvement Act of 2007 - Authorizes the Secretary of Housing and Urban Development, through the Office of Rural Housing and Economic Development, to implement an assistance program to support innovative housing and economic development activities in rural areas by: (1) Indian tribes; (2) state housing finance agencies; (3) state community or economic development agencies; (4) local nonprofit organizations; and (5) community development corporations. Directs the Secretary of Housing and Urban Development to require, as a condition of initial or continuing assistance under this Act for any housing or economic development activity, that each member of a family so assisted (or of a family applying for such assistance) who is 18 years of age or older, or is the spouse of the head of household, has a valid Social Security number. Authorizes appropriations for FY2008-FY2013.

rural housing economic development improvement act authorizes secretary housing_and_urban_development office rural housing economic development implement assistance program support innovative housing economic development activities rural areas indian tribes state housing finance agencies state community economic development agencies local nonprofit organizations community development corporations directs secretary housing_and_urban_development require condition initial continuing assistance act housing economic development activity member family assisted family applying assistance years age older spouse head household valid social_security number authorizes appropriations fy2008 fy2013


Summary: Empowerment Zone and Renewal Community Enhancement Act of 2007 - Amends Internal Revenue Code provisions relating to tax-preferred empowerment zones, rural enterprise communities, and renewal communities to: (1) extend the period of designation for such areas through 2015; (2) provide a safe harbor standard for employee residency requirements in empowerment zones; (3) eliminate certain residency requirements for the empowerment zone employment tax credit; (4) grant authority to expand the boundaries of empowerment zones and enterprise communities, including those located in rural areas; (5) allow carryovers of unused expensing allowances for enterprise zone businesses; (6) allow certain empowerment zone businesses to elect to receive payments in lieu of tax benefits; (7) allow federal guarantees and tax exemptions for enterprise zones and renewal communities; and (8) allow the issuance of tax-exempt rural enterprise community bonds.

empowerment zone renewal community enhancement_act 2007_-_amends_internal_revenue code provisions relating tax preferred empowerment zones rural enterprise communities renewal communities extend period designation areas provide safe harbor standard employee residency requirements empowerment zones eliminate certain residency requirements empowerment zone employment tax credit grant authority expand boundaries empowerment zones enterprise communities including located rural areas allow carryovers unused expensing allowances enterprise zone businesses allow certain empowerment zone businesses elect receive payments lieu tax benefits allow federal guarantees tax exemptions enterprise zones renewal communities allow issuance tax exempt rural enterprise community bonds


Summary: HOPE VI Improvement and Reauthorization Act of 2007 - Amends the United States Housing Act of 1937 to make promoting housing choice among low- and very low-income families one of the purposes of the HOPE VI grant program for revitalization of severely distressed public housing. Authorizes the Secretary of Housing and Urban Development to waive the matching contribution requirement in cases of extreme distress or emergency. Prohibits the award of demolition-only grants. Repeals authority for grants for assisting affordable housing developed through main street projects in smaller communities. Makes eligible for the use of HOPE VI grants: (1) necessary costs of ensuring the effective temporary and permanent relocation of residents displaced as a result of project revitalization; and (2) certain activities undertaken to comply with requirements for green developments and replacement housing for hard-to-house families. Revises criteria for selection of proposals for grants, divided into mandatory core components and mandatory graded components. Specifies requirements for mandatory core components of revitalization plans, including among others: (1) involvement of public housing residents in planning and implementation; (2) a temporary relocation program; (3) a right for resident households to expanded housing opportunities; (4) one-for-one replacement of demolished dwelling units; (5) monitoring of displaced households; and (6) green developments. Extends the HOPE VI program through FY2015.

hope improvement reauthorization act amends united_states_housing_act promoting housing choice low- low income families purposes hope grant program revitalization severely distressed public housing authorizes secretary housing_and_urban_development waive matching contribution requirement cases extreme distress emergency prohibits award demolition grants repeals authority grants assisting affordable housing developed main street projects smaller communities makes eligible use hope grants necessary costs ensuring effective temporary permanent relocation residents displaced result project revitalization certain activities undertaken comply requirements green developments replacement housing hard house families revises criteria selection proposals grants divided mandatory core components mandatory graded components specifies requirements mandatory core components revitalization plans including involvement public housing residents planning implementation temporary relocation program right resident households expanded housing opportunities replacement demolished dwelling units monitoring displaced households green developments extends hope program fy2015